These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 17107364)
21. A new intra-arterial delivery platform for pro-arteriogenic compounds to stimulate collateral artery growth via transforming growth factor-beta1 release. Grundmann S; van Royen N; Pasterkamp G; Gonzalez N; Tijsma EJ; Piek JJ; Hoefer IE J Am Coll Cardiol; 2007 Jul; 50(4):351-8. PubMed ID: 17659203 [TBL] [Abstract][Full Text] [Related]
22. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508 [TBL] [Abstract][Full Text] [Related]
23. Design criteria for the ideal drug-eluting stent. Ako J; Bonneau HN; Honda Y; Fitzgerald PJ Am J Cardiol; 2007 Oct; 100(8B):3M-9M. PubMed ID: 17950830 [TBL] [Abstract][Full Text] [Related]
24. Intravascular bioresorbable polymeric stents: a potential alternative to current drug eluting metal stents. Sharkawi T; Cornhill F; Lafont A; Sabaria P; Vert M J Pharm Sci; 2007 Nov; 96(11):2829-37. PubMed ID: 17979210 [TBL] [Abstract][Full Text] [Related]
25. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease. Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391 [TBL] [Abstract][Full Text] [Related]
26. The average stent length is longer and the average stent diameter is shorter in patients with drug-eluting stents versus bare-metal stents during percutaneous coronary intervention. Dilmanian H; Aronow WS; Mundia M; Pucillo AL; Weiss MB; Kalapatapu K; Monsen CE Am J Ther; 2007; 14(3):277-9. PubMed ID: 17515704 [TBL] [Abstract][Full Text] [Related]
27. Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent. Udipi K; Chen M; Cheng P; Jiang K; Judd D; Caceres A; Melder RJ; Wilcox JN J Biomed Mater Res A; 2008 Jun; 85(4):1064-71. PubMed ID: 17937416 [TBL] [Abstract][Full Text] [Related]
28. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Lüscher TF; Steffel J; Eberli FR; Joner M; Nakazawa G; Tanner FC; Virmani R Circulation; 2007 Feb; 115(8):1051-8. PubMed ID: 17325255 [TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents. Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823 [TBL] [Abstract][Full Text] [Related]
30. Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection. Ren X; Trilesskaya M; Kwan DM; Nguyen K; Shaw RE; Hui PY Am J Cardiol; 2009 Jul; 104(2):216-22. PubMed ID: 19576350 [TBL] [Abstract][Full Text] [Related]
31. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries. Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509 [TBL] [Abstract][Full Text] [Related]
32. TCT Daily: new trials set to examine drug-eluting stents: doctors urged to weigh benefits, risks of drug-eluting stents on per patient basis. J Interv Cardiol; 2007 Feb; 20(1):33. PubMed ID: 17300397 [No Abstract] [Full Text] [Related]
33. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation. Garg P; Mauri L Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745 [TBL] [Abstract][Full Text] [Related]
34. A review of current devices and a look at new technology: drug-eluting stents. Nakazawa G; Finn AV; Kolodgie FD; Virmani R Expert Rev Med Devices; 2009 Jan; 6(1):33-42. PubMed ID: 19105778 [TBL] [Abstract][Full Text] [Related]
35. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating. Jabara R; Chronos N; Robinson K Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646 [TBL] [Abstract][Full Text] [Related]
36. Urethral in situ biocompatibility of new drug-eluting biodegradable stents: an experimental study in the rabbit. Kotsar A; Isotalo T; Uurto I; Mikkonen J; Martikainen P; Talja M; Kellomäki M; Salenius JP; Tammela TL BJU Int; 2009 Apr; 103(8):1132-5. PubMed ID: 19040531 [TBL] [Abstract][Full Text] [Related]
37. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives. Ducrocq G; Serebruany V; Tanguay JF Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923 [TBL] [Abstract][Full Text] [Related]
39. [Efficacy and safety of implantation of multiple drug-eluting stents]. Fu Q; Li ZL; Wu HC Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):110-2. PubMed ID: 18227039 [TBL] [Abstract][Full Text] [Related]
40. [Development of drug coating on drug eluting stents]. Luo LL; Wang GX; Yin TY Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Mar; 30(2):117-9. PubMed ID: 16830805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]